Cargando…

Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer

This study aims to evaluate the radiation dosimetry of a new technetium-99m‒labelled small-molecule inhibitor of prostate-specific membrane antigen (HYNIC-Glu-Urea-A, (99m)Tc-HYNIC-PSMA) and its feasibility as a tumor-imaging agent in prostate cancer (PCa) patients. A total of 15 PCa patients were e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jianping, Zhang, Jiangang, Xu, Xiaoping, Lu, Linjun, Hu, Silong, Liu, Chang, Cheng, Jingyi, Song, Shaoli, Zhang, Yingjian, Shi, L. Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060171/ https://www.ncbi.nlm.nih.gov/pubmed/32144340 http://dx.doi.org/10.1038/s41598-020-61129-5

Ejemplares similares

Author Correction: Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

Patient-specific dosimetry of (99m)Tc-HYNIC-Tyr(3)-Octreotide in children
por: Hou, Xinchi, et al.
Publicado: (2017)

Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy
por: Li, Bo, et al.
Publicado: (2022)

The efficacy of (99m)Tc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastasis in newly diagnosed prostate cancer
por: Wang, Taisong, et al.
Publicado: (2023)

(99m)Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study
por: Lambert, Bieke, et al.
Publicado: (2016)

(99m)Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
por: Liepe, Knut, et al.
Publicado: (2018)

Clinical usefulness of (99m)Tc-HYNIC-TOC, (99m)Tc(V)-DMSA, and (99m)Tc-MIBI SPECT in the evaluation of pituitary adenomas
por: Vukomanovic, Vladimir R., et al.
Publicado: (2019)

Combination of (99m)Tc-Labeled PSMA-SPECT/CT and Diffusion-Weighted MRI in the Prediction of Early Response After Carbon Ion Therapy in Prostate Cancer: A Non-Randomized Prospective Pilot Study
por: Li, Ping, et al.
Publicado: (2021)

Comparing (99m)Tc-PSMA to (99m)Tc-MDP in Prostate Cancer Staging of the Skeletal System
por: Kabunda, Joseph, et al.
Publicado: (2021)

(99m)Tc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency
por: Kotzerke, Joerg, et al.
Publicado: (2014)

A novel molecular imaging probe [(99m)Tc]Tc-HYNIC-FAPI targeting cancer-associated fibroblasts
por: Jiang, Yanghongyan, et al.
Publicado: (2023)

EDB Fibronectin-Specific SPECT Probe (99m)Tc-HYNIC-ZD2 for Breast Cancer Detection
por: Ye, Xiao-Xuan, et al.
Publicado: (2017)

Preparation and Biological Evaluation of [(99m)Tc]Tc-CNGU as a PSMA-Targeted Radiotracer for the Imaging of Prostate Cancer
por: Xiao, Di, et al.
Publicado: (2020)

(99m)Tc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies
por: Schaper, Frédéric L.W.V.J., et al.
Publicado: (2013)

Value of Somatostatin Receptor Scintigraphy with (99m)Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
por: Anzola, Luz Kelly, et al.
Publicado: (2019)

Diagnostic accuracy of (99m)Tc-HYNIC-TOC SPECT/CT for detecting osteomalacia-associated tumors
por: Li, Bo, et al.
Publicado: (2023)

Preparation and Bioevaluation of Novel (99m)Tc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia
por: Ruan, Qing, et al.
Publicado: (2021)

Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of (99m)Tc-Hynic-rh-Annexin V Imaging
por: Kartachova, M.S., et al.
Publicado: (2008)

In-Vivo Biodistribution and Safety of (99m)Tc-LLP2A-HYNIC in Canine Non-Hodgkin Lymphoma
por: Zwingenberger, Allison L., et al.
Publicado: (2012)

Synthesis and Optimization of the Labeling Procedure of (99m)Tc-Hynic-Interleukin-2 for In vivo Imaging of Activated T lymphocytes
por: D’Alessandria, Calogero, et al.
Publicado: (2009)

A (99m)Tc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging
por: Shamshirian, Danial, et al.
Publicado: (2016)

(99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging
por: Ahmadpour, Sajjad, et al.
Publicado: (2018)

Comparison of the Absorbed Dose for (99m)Tc-Diethylenetriaminepentaacetic Acid and (99m)Tc-Ethylenedicysteine Radiopharmaceuticals using Medical Internal Radiation Dosimetry
por: Pirdamooie, Shokufeh, et al.
Publicado: (2015)

Evaluation of (99m)Tc-HYNIC-VCAM-1(scFv) as a Potential Qualitative and Semiquantitative Probe Targeting Various Tumors
por: Zhang, Xiao, et al.
Publicado: (2018)

SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis
por: Luo, Xiu, et al.
Publicado: (2023)

Development of in-House Synthesis and Quality Control of [(99m)Tc]Tc-PSMA-I&S
por: Plhak, Elisabeth, et al.
Publicado: (2023)

Evaluation of (99m)Tc-HYNIC-βAla-Bombesin((7-14)) as an agent for pancreas tumor detection in mice
por: Carlesso, F.N., et al.
Publicado: (2015)

Multiple Cutaneous Metastases on (99m)TC-HYNIC-TOC Scan in a Rare Case of Malignant Laryngeal Paraganglioma
por: Sankar, Gowri, et al.
Publicado: (2018)

Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC
por: Xiao, Zunyu, et al.
Publicado: (2017)

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022)

A Review on the Current State and Future Perspectives of [(99m)Tc]Tc-Housed PSMA-i in Prostate Cancer
por: Brunello, Sara, et al.
Publicado: (2022)

Head-to-head comparison of (99m)Tc-PSMA and (99m)Tc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
por: Zhang, Yu, et al.
Publicado: (2022)

Evaluation of [(99m)Tc][Tc-HYNIC/EDDA]-Tyr as a target for metabolic tumor imaging in B16F10 melanoma tumor
por: Yaghoubi Mogadam, Hemat, et al.
Publicado: (2022)

Direct comparison of (99m)Tc-PSMA SPECT/CT and (68)Ga-PSMA PET/CT in patients with prostate cancer
por: Albalooshi, Batool, et al.
Publicado: (2020)

Biokinetics, dosimetry, and radiation risk in infants after (99m)Tc-MAG3 scans
por: Soares Machado, J., et al.
Publicado: (2018)

[(99cm)Tc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
por: Werner, P., et al.
Publicado: (2020)

Initial Experience of Clinical Use of [(99m)Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
por: Ćwikła, Jarosław B., et al.
Publicado: (2021)

In vivo(99m)Tc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation
por: Guo, Ming-fang, et al.
Publicado: (2009)

The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
por: Koçyiğit Deveci, Emel, et al.
Publicado: (2013)

Automated synthesis and quality control of [(99m)Tc]Tc-PSMA for radioguided surgery (in a [(68)Ga]Ga-PSMA workflow)
por: Aalbersberg, Else A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sb19jt1aem0fb6degdem0o3ks3